Predilife S.A. (EPA: ALPRE) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ALPREPredilife S.A.

EPA · FR · Healthcare · Diagnostics & Research · predilife.com

1.805EUR0.00%Mkt Cap: 7.73M $P/E: —2d ago

Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a n…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap7.73M $

Enterprise Value11.63M $

Revenue (TTM)908.49K $

Gross Profit1.20M $

Net Income (TTM)-3.83M $

Revenue/Share0.2304 USD

Last Price1.805 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees20

CountryFR

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.29

EV/Revenue12.80

P/S7.07

P/B-0.37

EPS (TTM)-1.00

EPS (Forward)—

52W Range

1.8050% of range4.000

52W High4.000 EUR

52W Low1.805 EUR

Profitability

Gross Margin98.86%

Oper. Margin-380.15%

EBITDA Margin0.00%

Profit Margin-315.27%

ROE50.98%

ROA-192.24%

Growth

Revenue Growth32.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.79M $

CapEx (TTM)2.21K $

FCF Margin-154.97%

FCF Yield-18.21%

Net Debt5.19M $

Net Debt/EBITDA-1.47

Balance Sheet

Debt/Equity-0.80

Current Ratio0.56

Quick Ratio0.55

Book Value/Sh-4.0020 EUR

Cash/Share0.1890 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.3.94M

Float—

Insiders50.95%

Institutions0.00%

Technical

SMA 502.529 (-28.6%)

SMA 2003.018 (-40.2%)

Beta0.30

S&P 52W Chg20.25%

Avg Vol (30d)718

Avg Vol (10d)395

Technical Indicators

RSI (14)24.1

MACD-0.2238

MACD Signal-0.1871

MACD Hist.-0.0367

BB Upper2.737 EUR

BB Middle2.195 EUR

BB Lower1.653 EUR

BB Width49.37%

ATR (14)0.1080 EUR

Vol Ratio (20d)0.00x